文献速递瓣膜外科

70岁以上患者机械瓣与生物瓣主动脉瓣置换的长期结局

Long-term Outcomes of Mechanical Vs Biologic Aortic Valve Prosthesis in Patients Older Than 70 Years.
PubMed 文献 · Ann Thorac Surg · 2019-05-10

该回顾性研究纳入芬兰2004至2014年70岁以上首次孤立主动脉瓣置换患者4227例,经倾向评分匹配后比较机械瓣与生物瓣的长期结局。匹配后机械瓣组296例、生物瓣组888例,平均年龄75.8岁,平均随访8.3年。结果显示机械瓣组10年生存率更低(46.1% vs 57.8%),大出血发生率更高(37.0% vs 18.8%),缺血性卒中、感染性心内膜炎和主动脉瓣再手术无显著差异。

要点

  • 70岁以上患者机械瓣较生物瓣10年生存率更低(46.1% vs 57.8%)。
  • 机械瓣组10年大出血率更高(37.0% vs 18.8%),胃肠道和颅内出血均增加。
  • 缺血性卒中、感染性心内膜炎和再手术率两组无显著差异。

核心结论

  • 70岁以上患者行主动脉瓣置换时,机械瓣与更差的长期生存和更多出血相关,应谨慎考虑机械瓣。

研究设计与样本

  • 芬兰2004至2014年回顾性研究,纳入70岁以上首次孤立主动脉瓣置换(伴或不伴冠状动脉旁路移植)患者4227例,排除心内膜炎。
  • 采用1:3倾向评分匹配,匹配后机械瓣组296例、生物瓣组888例,平均年龄75.8岁,平均随访8.3年。

主要发现

  • 10年生存率机械瓣组46.1%,生物瓣组57.8%(HR 1.48,95%CI 1.21至1.80,P < .001,需伤害人数7.0)。
  • 10年大出血率机械瓣组37.0%,生物瓣组18.8%(HR 1.77,95%CI 1.25至2.49,P = .001,需伤害人数7.4)。
  • 胃肠道出血机械瓣组26.5%,生物瓣组8.9%(HR 2.63,95%CI 1.63至4.23,P < .001)。
  • 颅内出血机械瓣组8.8%,生物瓣组6.0%(HR 2.12,95%CI 1.09至4.15,P = .028)。
  • 缺血性卒中(18.9% vs 16.1%,P = .341)、感染性心内膜炎(3.7% vs 2.8%,P = .242)、主动脉瓣再手术(0.8% vs 2.8%,P = .707)两组无显著差异。

临床怎么用

  • 70岁以上患者选择主动脉瓣置换瓣膜类型时,应权衡机械瓣的生存劣势和出血风险,谨慎使用机械瓣。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Biologic prostheses are preferred for surgical aortic valve replacement (SAVR) in patients more than 70 years of age in clinical practice. This study investigated differences in long-term outcomes between SAVR-treated patients more than 70 years of age who received mechanical or biologic prosthetic valves. METHODS: All patients (excluding those with endocarditis) who were more than 70 years of age and who underwent isolated first-time SAVR (with or without coronary artery bypass grafting) in Finland between 2004 and 2014 were retrospectively studied (n = 4227). Propensity score matching (1:3) was used to account for baseline differences (n = 296 with mechanical prostheses and n = 888 with biologic prostheses). Outcomes were 10-year survival, major bleeding (all, gastrointestinal, intracranial), ischemic stroke, infective endocarditis, and aortic valve reoperation. Mean age was 75.8 years, and mean follow-up was 8.3 years. RESULTS: Survival at 10 years was 46.1% with mechanical prostheses and 57.8% with biologic prostheses (hazard ratio [HR], 1.48; 95% confidence interval [CI], 1.21 to 1.80; P < .001; number needed to harm = 7.0). The 10-year major bleeding rates were 37.0% with mechanical valves and 18.8% with biologic valves (HR, 1.77; 95% CI, 1.25 to 2.49; P = .001; number needed to harm = 7.4). Both gastrointestinal bleeding (26.5% vs 8.9%; HR, 2.63; 95% CI, 1.63 to 4.23; P < .001) and intracranial bleeding (8.8% vs 6.0%; HR, 2.12; 95% CI, 1.09 to 4.15; P = .028) were significantly more frequent with mechanical valve prosthesis. Occurrence of ischemic stroke (18.9% with mechanical prosthesis vs 16.1% with biologic prosthesis; P = .341), infective endocarditis (3.7% vs 2.8%; P = .242), or aortic valve reoperation (0.8% vs 2.8%; P = .707) did not differ between study groups. CONCLUSIONS: Mechanical aortic valve prosthesis is associated with worse long-term survival and increased bleeding after SAVR in patients more than 70 years old. The study results suggest caution when considering mechanical aortic valve prostheses in elderly patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kytö V, Myllykangas ME, Sipilä J, et al. Long-term Outcomes of Mechanical Vs Biologic Aortic Valve Prosthesis in Patients Older Than 70 Years. Ann Thorac Surg. 2019. PMID: 31082357. doi:10.1016/j.athoracsur.2019.04.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。